Ausgabe 4/2017
Inhalt (21 Artikel)
Up front
Towards a systematic nationwide screening strategy for MODY
Beverley Shields, Kevin Colclough
Emerging role of intestinal microbiota and microbial metabolites in metabolic control
Hilde Herrema, Richard G. IJzerman, Max Nieuwdorp
Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes
Graham R. Law, Mark S. Gilthorpe, Anna L. Secher, Rosemary Temple, Rudolf Bilous, Elisabeth R. Mathiesen, Helen R. Murphy, Eleanor M. Scott
Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry
Bente B. Johansson, Henrik U. Irgens, Janne Molnes, Paweł Sztromwasser, Ingvild Aukrust, Petur B. Juliusson, Oddmund Søvik, Shawn Levy, Torild Skrivarhaug, Geir Joner, Anders Molven, Stefan Johansson, Pål R. Njølstad
Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012
Cécile Billionnet, Delphine Mitanchez, Alain Weill, Jacky Nizard, François Alla, Agnès Hartemann, Sophie Jacqueminet
Differential methylation of genes in individuals exposed to maternal diabetes in utero
Peng Chen, Paolo Piaggi, Michael Traurig, Clifton Bogardus, William C. Knowler, Leslie J. Baier, Robert L. Hanson
Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes
Laura Marroqui, Reinaldo S. Dos Santos, Anne Op de beeck, Alexandra Coomans de Brachène, Lorella Marselli, Piero Marchetti, Decio L. Eizirik
Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes
Ting Yuan, Sahar Rafizadeh, Kanaka Durga Devi Gorrepati, Blaz Lupse, Jose Oberholzer, Kathrin Maedler, Amin Ardestani
Targeted deletion of Traf2 allows immunosuppression-free islet allograft survival in mice
Jeanette E. Villanueva, Stacey N. Walters, Mitsuru Saito, Elisabeth K. Malle, Nathan W. Zammit, Katherine A. Watson, Robert Brink, Nicole L. La Gruta, Stephen I. Alexander, Shane T. Grey
Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice
Vincent Blasco-Baque, Berengère Coupé, Aurelie Fabre, Sandra Handgraaf, Pierre Gourdy, Jean-François Arnal, Michael Courtney, Carole Schuster-Klein, Beatrice Guardiola, François Tercé, Rémy Burcelin, Matteo Serino
Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels
Joshua R. Willard, Breanne M. Barrow, Sakeneh Zraika
Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile
Adam D. Farmer, Anne Grave Pedersen, Birgitte Brock, Poul Erik Jakobsen, Jesper Karmisholt, Sahar D. Mohammed, S. Mark Scott, Asbjørn Mohr Drewes, Christina Brock
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy
Sara Rezzola, Michela Corsini, Paola Chiodelli, Anna Cancarini, Imtiaz M. Nawaz, Daniela Coltrini, Stefania Mitola, Roberto Ronca, Mirella Belleri, Liliana Lista, Dario Rusciano, Mario De Rosa, Vincenzo Pavone, Francesco Semeraro, Marco Presta
AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin
Emma Börgeson, Ville Wallenius, Gulam H. Syed, Manjula Darshi, Juan Lantero Rodriguez, Christina Biörserud, Malin Ragnmark Ek, Per Björklund, Marianne Quiding-Järbrink, Lars Fändriks, Catherine Godson, Kumar Sharma
Enhanced VEGF signalling mediates cerebral neovascularisation via downregulation of guidance protein ROBO4 in a rat model of diabetes
Mohammed Abdelsaid, Maha Coucha, Sherif Hafez, Abdul Yasir, Maribeth H. Johnson, Adviye Ergul
Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary?
Martha L. Campbell-Thompson, Mark A. Atkinson, Alexandra E. Butler, Ben N. Giepmans, Matthias G. von Herrath, Heikki Hyöty, Thomas W. Kay, Noel G. Morgan, Alvin C. Powers, Alberto Pugliese, Sarah J. Richardson, Peter A. In’t Veld
Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary? Reply to Campbell-Thompson ML, Atkinson MA, Butler AE et al [letter]
Marcus Lundberg, Peter Seiron, Sofie Ingvast, Olle Korsgren, Oskar Skog
Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
Emily J. Gallagher, Zara Zelenko, Aviva Tobin-Hess, Ulrich Werner, Norbert Tennagels, Derek LeRoith